Money & Medicine
Special | 13m 3s
Dr. Jerome Kassirer, former editor-in-chief of the New England Journal of Medicine discusses the state of the FDA today and the conditions that make it possible for drugs such as Fen-phen, Vioxx and now Avandia, the latest drug that may be pulled from the market, to reach consumers. Jon Meacham reports.
Problems Playing Video? | Closed Captioning